NIP
IMCR icon

Nicholas Investment Partners’s Immunocore IMCR Stock Holding History

Nicholas Investment Partners’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-77,455
Closed -$5.03M – 216
2024
Q1 		$5.03M Buy
77,455
+25,296
+48% +$1.74M 0.52% 69
2023
Q4 		$3.56M Sell
52,159
-460,696
-90% -$23.9M 0.42% 91
2023
Q3 		$26.6M Buy
512,855
+508,155
+10,812% +$30.1M 1.99% 14
2023
Q2 		$282K Buy
+4,700
New +$268K 0.02% 187

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Nicholas Investment Partners's IMCR Position: Q2 2024 in Review

Nicholas Investment Partners sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 77,455 shares — an estimated $5.03M sold.

Nicholas Investment Partners first reported a position in IMCR in Q2 2023 and held it in 4 quarters. The position peaked at $26.6M in Q3 2023. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Nicholas Investment Partners reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 77,455 Immunocore shares in Q2 2024, an estimated $5.03M.
  • Nicholas Investment Partners first reported a position in Immunocore in Q2 2023 and held it in 4 quarters.
  • Nicholas Investment Partners's Immunocore position peaked at $26.6M in Q3 2023.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Nicholas Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.